Atracurium besilate 25mg/2.5ml solution for injection ampoules
Requires a prescription from a doctor or prescriber
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Official medicine documents
Yellow Card
Report side effects (MHRA)
Drug safety updates
MHRA alerts for Atracurium
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Suspected adverse reactions reported for Atracurium
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
View EudraVigilance report
Suspected adverse reactions reported for Atracurium
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
9 branded products available
MHRA licensed products
View all licensed products for Atracurium on the MHRA register
Atracurium besilate 25mg/2.5ml solution for injection ampoules
Atracurium besilate 25mg/2.5ml solution for injection ampoules
Atracurium besilate 25mg/2.5ml solution for injection ampoules
Therapeutically similar medicines
Similarity is based on WHO Anatomical Therapeutic Chemical (ATC) classification and on a factual NHS dm+d therapeutic-grouping code prefix. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
Browse tools
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. ATC codes from the WHO Collaborating Centre for Drug Statistics Methodology (whocc.no).
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing the 50 most relevant studies.
Reviews & meta-analyses: 3 · Randomised trials: 11 · 1981–2025
Showing the 50 most relevant studies, sorted by most relevant.
X. Durrmeyer, S. Breinig, O. Claris, et al.
JAMA, 2018
Shilpa Bansal, Mridul M Pandit Rao, Minnu Mridul Pandit Rao
Journal of Clinical and Diagnostic Research, 2023
Mohammad Alipour, Samira Ghanei, Shahrzad Sheikh, et al.
BMC Research Notes, 2025
Maryam Shabbir, Muhammad Aatir Fayyaz, Muhammad Adnan
Medeye Publishers, 2025
Atracurium and cisatracurium are commonly used non-depolarizing neuromuscular blocking agents during general anesthesia. Their comparative effects on onset of complete neuromuscular blockade and early hemodynamic stability remain clinically relevant in elective abdominal surgery. Objective: To compare cisatracurium and atracurium in terms of hemodynamic status and time to achieve complete neuromuscular blockade among patients undergoing elective abdominal surgeries. Methods: This randomized controlled trial was conducted in the Department of Anesthesia, Nishtar University Hospital, Multan, Pakistan, from December 2023 to December 2024. A total of 278 ASA-I patients aged 18–50 years undergoing elective abdominal surgery under general anesthesia were included. Patients were divided into two equal groups: Group A received atracurium 0.5 mg/kg, while Group B received cisatracurium 0.2 mg/kg. Neuromuscular blockade was assessed using train-of-four monitoring. Heart rate and mean arterial pressure were recorded at baseline and at one-minute intervals for 10 minutes after drug administration. Data were analyzed using SPSS version 23, and p<0.05 was considered statistically significant. Results: The mean age of patients was 35.42 ± 7.03 years, and 151 (54.3%) were male. Baseline demographic and operative characteristics were comparable between the groups. Cisatracurium produced significantly faster complete neuromuscular blockade than atracurium, with a mean time to TOF score 0 of 169.12 ± 16.17 seconds versus 186.16 ± 13.77 seconds, respectively (p<0.001). A higher proportion of patients in the cisatracurium group achieved TOF score 0 within 180 seconds compared with the atracurium group (76.3% vs 33.1%, p<0.001). Atracurium was associated with a mild early rise in heart rate and greater early reduction in mean arterial pressure, while cisatracurium showed better early hemodynamic stability. Conclusion: Cisatracurium was superior to atracurium in achieving earlier complete neuromuscular blockade with more stable early hemodynamic response.</jats:p
Abstract licence: CC BY-NC
Rana Imran Sikander, Muhammad Haroon Anwar, Javeriah Khan, et al.
Shaheed Zulfiqar Ali Bhutto Medical University, 2024
H. Berg, J. Viby-Mogensen, J. Roed, et al.
Acta Anaesthesiologica Scandinavica, 1997
K. Leslie, Daniel I. Sessler, A. Bjorksten, et al.
Anesthesia & Analgesia, 1995
E. Sundman, H. Witt, R. Olsson, et al.
Anesthesiology, 2000
Ronald D. Miller, S. Rupp, D. Fisher, et al.
Anesthesiology, 1984
R. Hughes, D. Chapple
British journal of anaesthesia, 1981
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Pharmacology and chemical data from DrugBank
Key facts
Drug status
Approved
Major interactions
1 found
Half-life
Not available
Mechanism
Not available
Food interactions
None known
Human targets
None mapped
Data: DrugBank · CC BY-NC 4.0
Pharmacokinetics at a glance
Known interactions with other medicines. Always consult a healthcare professional.
Showing 50 of 1119 interactions
ATC M03AC04
Chemical identifiers
CAS, UNII, InChI Key and database cross-references
Show
Chemical identifiers
CAS, UNII, InChI Key and database cross-references
Linked compound data from DrugBank Open Data (CC BY-NC 4.0)
Atracurium
DrugBank citations
If you use DrugBank data in your research, please cite:
- DrugBank 6.02024Recommended citationKnox C., Wilson M., Klinger C.M., et alDrugBank 6.0: the DrugBank Knowledgebase for 2024Nucleic Acids Res. 2024 Jan 552(D1):D1265-D1275
- DrugBank 5.02018Wishart D.S., Feunang Y.D., Guo A.C., et alDrugBank 5.0: a major update to the DrugBank database for 2018Nucleic Acids Res. 2017 Nov 846(D1):D1074-D1082
- DrugBank 4.02014Law V., Knox C., Djoumbou Y., et alDrugBank 4.0: shedding new light on drug metabolismNucleic Acids Res. 2014 Jan 142(1):D1091-7
- DrugBank 3.02011Knox C., Law V., Jewison T., et alDrugBank 3.0: a comprehensive resource for 'omics' research on drugsNucleic Acids Res. 2011 Jan39(Database issue):D1035-41
- DrugBank 2.02008Wishart D.S., Knox C., Guo A.C., et alDrugBank: a knowledgebase for drugs, drug actions and drug targets.Nucleic Acids Research2008 Jan36(Database issue):D901-6
- DrugBank 1.02006Wishart D.S., Knox C., Guo A.C., et alDrugBank: a comprehensive resource for in silico drug discovery and exploration.Nucleic Acids Research2006 Jan 134(Database issue):D668-72